Intralesion and curaderm BEC5 topical combination therapies of solasodine rhamnosyl glycosides derived from the eggplant or Devil’s apple result in rapid removal of large skin cancers. methods of treatment compared

Intralesion and curaderm BEC5 topical combination therapies of solasodine rhamnosyl glycosides derived from the eggplant or Devil’s apple result in rapid removal of large skin cancers. methods of treatment compared

2012

E05054

Solasodine rhamnosyl glycosides (SRGs) are chemotherapeutic agents for the treatment of cancer. SRGs in a cream formulation, Curaderm BEC5 , is very effective for the treatment of nonmelanoma skin cancers with excellent cosmetic end results. Intralesion injection of SRGs successfully dispose of very large tumours in animals without any clinical adverse effects. The mode of action of SRGs is by apoptosis. In this study, it is shown that small to large basal cell carcinomas are effectively treated only with topical application of Curaderm BEC5 . Here it is reported for the first time that combination of intralesion SRG injection and topical application with Curaderm BEC5 in humans reduces the treatment time period by more than half when compared with topical application as the sole treatment regime. Two intralesion\n injections of very low doses of SRGs rapidly and effectively remove a large melanoma on a horse. If rapid removal of large troublesome skin cancers is required then this can be achieved by intralesion and topical treatments. Intralesion or combination therapy with SRGs may have some applications for melanomas in situ such as lentigo maligna.

3:115-124, INTERNATINAL JOURNAL OF CLINICAL MEDICINE

Research > Published Articles